Literature DB >> 9631402

Commentary: extraocular muscle sparing in muscular dystrophy: a critical evaluation of potential protective mechanisms.

J D Porter1.   

Abstract

Muscles or muscle groups exhibiting responses to neuromuscular disease that are unlike those of other skeletal muscles may provide novel information about pathogenesis leading to improved treatment strategies. The author's laboratory studies the relationship between the unique phenotype of the extraocular muscles and their selective sparing or targeting in neuromuscular disease. This commentary evaluates the evidence for and against four hypotheses for the selective protection of extraocular muscle in Duchenne muscular dystrophy (DMD) and merosin-deficient congenital muscular dystrophy (CMD).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9631402     DOI: 10.1016/s0960-8966(98)00015-7

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  7 in total

Review 1.  Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors.

Authors:  Jane T Seto; Julian N Ramos; Lindsey Muir; Jeffrey S Chamberlain; Guy L Odom
Journal:  Curr Gene Ther       Date:  2012-06       Impact factor: 4.391

2.  Extraocular muscle satellite cells are high performance myo-engines retaining efficient regenerative capacity in dystrophin deficiency.

Authors:  Pascal Stuelsatz; Andrew Shearer; Yunfei Li; Lindsey A Muir; Nicholas Ieronimakis; Qingwu W Shen; Irina Kirillova; Zipora Yablonka-Reuveni
Journal:  Dev Biol       Date:  2014-09-16       Impact factor: 3.582

3.  Glucose uptake in rat extraocular muscles: effect of insulin and contractile activity.

Authors:  Mary L Garcia-Cazarin; Tatijana M Fisher; Francisco H Andrade
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-08-11       Impact factor: 4.799

4.  Comparative evolution of muscular dystrophy in diaphragm, gastrocnemius and masseter muscles from old male mdx mice.

Authors:  J Muller; N Vayssiere; M Royuela; M E Leger; A Muller; F Bacou; F Pons; G Hugon; D Mornet
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

Review 5.  Gene therapy in large animal models of muscular dystrophy.

Authors:  Zejing Wang; Jeffrey S Chamberlain; Stephen J Tapscott; Rainer Storb
Journal:  ILAR J       Date:  2009

6.  Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient mice.

Authors:  Guy L Odom; Paul Gregorevic; James M Allen; Eric Finn; Jeffrey S Chamberlain
Journal:  Mol Ther       Date:  2008-07-29       Impact factor: 11.454

7.  Muscle Progenitors Derived from Extraocular Muscles Express Higher Levels of Neurotrophins and their Receptors than other Cranial and Limb Muscles.

Authors:  Génova Carrero-Rojas; Beatriz Benítez-Temiño; Angel M Pastor; Mª América Davis López de Carrizosa
Journal:  Cells       Date:  2020-03-18       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.